Profex raises new funds for business expansion
This article was originally published in Scrip
Executive Summary
The Chinese dermatology firm Profex has raised $15.5 million in a series A financing led by the US venture capital firm Trident Capital. It will use the proceeds to license in additional products and for general corporate development purposes.